Truist Financial analyst David S Macdonald reiterated a Buy rating on CVS Health (CVS – Research Report) today and set a price target of ...
CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall ...
After a dismal 2024, CVS Health (NYSE:CVS) could be starting to turn itself around. Some investors seem convinced, especially after the retail drugstore chain on Wednesday posted a big beat on ...
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Encompass Health (EHC – Research Report), with a ...
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Humana shares were rising early Tuesday after the health insurer said it expects its earnings this year to be broadly flat.
CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...
Lawmakers determined to enact new restrictions on pharmacy benefit managers are trying to include legislation, which nearly ...
The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...
For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.